Outcomes of Radical Nephrectomy With Caval Tumour Thrombectomy Including a Novel Two‐Stage Approach
ANZ Journal of Surgery · 2025
DOI: 10.1111/ans.70404 ↗At a glance
Journal article in ANZ Journal of Surgery, 2025. Written by Daniel Crisafi and 14 co-authors. Institution: Department of Urology, Austin Health, Melbourne, Australia. Major MEDLINE topics: Thrombectomy, Nephrectomy, Kidney Neoplasms, Carcinoma, Renal Cell. 30 references.
Abstract (original language)
Background
Renal vein and caval tumour extension occurs in 10%–25% of patients with renal cell carcinoma. This study aims to examine perioperative morbidity and survival outcomes after radical nephrectomy with inferior vena cava tumour thrombectomy at a quaternary institution in Australia.
Methods
This was a retrospective review of nephrectomy with tumour thrombectomy cases between June 2012 and 2022 at a single centre, followed up until September 2024. Overall survival (OS) was visualised by Kaplan–Meier plots and comparisons between survival by presence of metastases, margin status, and thrombus level (I‐III vs. IV) were explored with the log‐rank test. Recurrence‐free survival (RFS) in patients without initial metastases was also examined.
Results
We identified 39 patients, 25 (64%) were male and the median (IQR) age was 64 years (55–69). Metastatic disease was present in 14 patients (36%). Nineteen (49%) had level IV (supradiaphragmatic) tumour thrombus involvement. Six patients (15%) died in hospital, including two intraoperative deaths. A further 14 (36%) experienced Clavien‐Dindo grade III or IV complications during their hospital stay. The median OS was 57 months (95% CI: 17–not reached). Excluding those who died in hospital, the median OS was 60 months (95% CI: 33–not reached). There was a significant difference in OS observed by the presence of metastatic disease ( p = 0.003), but not with margin status ( p = 0.35) or thrombus level ( p = 0.22). The median RFS for M0 patients was 60 months (95% CI: 8–not reached).
Conclusion
While associated with high morbidity and mortality, nephrectomy and caval thrombectomy remain an effective treatment option for otherwise fatal advanced RCC.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Urology, Austin Health, Melbourne, Australia.
- Department of Vascular Surgery, Austin Health, Melbourne, Australia.
- Department of Hepatobiliary Surgery, Austin Health, Melbourne, Australia.
- Department of Surgery, The University of Melbourne, Melbourne, Australia.
- Department of Cardiac Surgery, Austin Health, Melbourne, Australia.
- Department of Anaesthesia, Austin Health, Melbourne, Australia.
ORCID profiles: Daniel Crisafi, Anne Hong, Kirby R Qin, Joel Ding, Siven Seevanayagam
Cite
APA
Crisafi, D., Hong, A., Papa, N., Obrecht, F., Qin, K. R., Ding, J., Perini, M. V., Seevanayagam, S., McCall, P., Chuen, J., Qi, S., Jack, G., Ischia, J., Bolton, D., & Woon, D. T. S. (2025). Outcomes of Radical Nephrectomy With Caval Tumour Thrombectomy Including a Novel Two‐Stage Approach. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70404
Vancouver
Crisafi D, Hong A, Papa N, Obrecht F, Qin KR, Ding J, et al. Outcomes of Radical Nephrectomy With Caval Tumour Thrombectomy Including a Novel Two‐Stage Approach. ANZ Journal of Surgery. 2025. doi:10.1111/ans.70404
BibTeX
@article{Crisafi2025,
author = {Crisafi, Daniel and Hong, Anne and Papa, Nathan and Obrecht, Fabian and Qin, Kirby R and Ding, Joel and Perini, Marcos Vinicius and Seevanayagam, Siven and McCall, Peter and Chuen, Jason and Qi, Sara and Jack, Gregory and Ischia, Joseph and Bolton, Damien and Woon, Dixon T S},
title = {Outcomes of Radical Nephrectomy With Caval Tumour Thrombectomy Including a Novel Two‐Stage Approach},
journal = {ANZ Journal of Surgery},
year = {2025},
doi = {10.1111/ans.70404}
}
EUVIMED